Cargando…
SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study
BACKGROUND: There are several ecological studies, but few studies of the prevalence of SARS-COV-2 at high altitude. We aimed to estimate the population-based seroprevalence of SARS-COV-2 in three settings of Cusco at the end of the first wave among adults. METHODS: A population-based survey was cond...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459728/ https://www.ncbi.nlm.nih.gov/pubmed/34616616 http://dx.doi.org/10.7717/peerj.12149 |
_version_ | 1784571589719752704 |
---|---|
author | Huamaní, Charles Velásquez, Lucio Montes, Sonia Mayanga-Herrera, Ana Bernabé-Ortiz, Antonio |
author_facet | Huamaní, Charles Velásquez, Lucio Montes, Sonia Mayanga-Herrera, Ana Bernabé-Ortiz, Antonio |
author_sort | Huamaní, Charles |
collection | PubMed |
description | BACKGROUND: There are several ecological studies, but few studies of the prevalence of SARS-COV-2 at high altitude. We aimed to estimate the population-based seroprevalence of SARS-COV-2 in three settings of Cusco at the end of the first wave among adults. METHODS: A population-based survey was conducted in September 2020, in three settings in the region of Cusco: (1) Cusco city at 3,300 meters above the sea level (m.a.s.l.), (2) the periphery of Cusco (Santiago, San Jerónimo, San Sebastián, and Wanchaq) at 3,300 m.a.s.l., and (3) Quillabamba city, located at 1,050 m.a.s.l. People aged ≥ 18 years within a family unit were included. The diagnosis of SARS-CoV-2 infection was based on identifying anti- SARS-CoV-2 total antibodies (IgM and IgG) in serum using the Elecsys Anti-SARS-CoV-2 chemiluminescence test. RESULTS: We enrolled 1924 participants from 712 families. Of the total, 637 participants were anti-SARS-CoV-2 seropositive. Seroprevalence was 38.8% (95% CI [33.4%–44.9%]) in Cusco city, 34.9% (95% CI [30.4%–40.1%]) in the periphery of Cusco, and 20.3% (95% CI [16.2%–25.6%]) in Quillabamba. In 141 families (19.8%; 95% CI [17.0%–22.8%]) the whole members were positive to the test. Living with more than three persons in the same house, a positive COVID-19 case at home, and a member who died in the last five months were factors associated with SARS-COV-2 seropositivity. Dysgeusia/dysosmia was the symptom most associated with seropositivity (aPR = 2.74, 95% CI [2.41–3.12]); whereas always wearing a face shield (aPR = 0. 73; 95% CI [0.60–0.89]) or a facial mask (aPR = 0.76, 95% CI [0.63–0. 92) reduced that probability. CONCLUSIONS: A great proportion of Cusco’s city inhabitants presented anti-SARS-CoV-2 antibodies at the end of the first wave, with significant differences between settings. Wearing masks and face shields were associated with lower rate of seropositivity; however, efforts must be made to sustain them over time since there is still a high proportion of susceptible people. |
format | Online Article Text |
id | pubmed-8459728 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84597282021-10-05 SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study Huamaní, Charles Velásquez, Lucio Montes, Sonia Mayanga-Herrera, Ana Bernabé-Ortiz, Antonio PeerJ Virology BACKGROUND: There are several ecological studies, but few studies of the prevalence of SARS-COV-2 at high altitude. We aimed to estimate the population-based seroprevalence of SARS-COV-2 in three settings of Cusco at the end of the first wave among adults. METHODS: A population-based survey was conducted in September 2020, in three settings in the region of Cusco: (1) Cusco city at 3,300 meters above the sea level (m.a.s.l.), (2) the periphery of Cusco (Santiago, San Jerónimo, San Sebastián, and Wanchaq) at 3,300 m.a.s.l., and (3) Quillabamba city, located at 1,050 m.a.s.l. People aged ≥ 18 years within a family unit were included. The diagnosis of SARS-CoV-2 infection was based on identifying anti- SARS-CoV-2 total antibodies (IgM and IgG) in serum using the Elecsys Anti-SARS-CoV-2 chemiluminescence test. RESULTS: We enrolled 1924 participants from 712 families. Of the total, 637 participants were anti-SARS-CoV-2 seropositive. Seroprevalence was 38.8% (95% CI [33.4%–44.9%]) in Cusco city, 34.9% (95% CI [30.4%–40.1%]) in the periphery of Cusco, and 20.3% (95% CI [16.2%–25.6%]) in Quillabamba. In 141 families (19.8%; 95% CI [17.0%–22.8%]) the whole members were positive to the test. Living with more than three persons in the same house, a positive COVID-19 case at home, and a member who died in the last five months were factors associated with SARS-COV-2 seropositivity. Dysgeusia/dysosmia was the symptom most associated with seropositivity (aPR = 2.74, 95% CI [2.41–3.12]); whereas always wearing a face shield (aPR = 0. 73; 95% CI [0.60–0.89]) or a facial mask (aPR = 0.76, 95% CI [0.63–0. 92) reduced that probability. CONCLUSIONS: A great proportion of Cusco’s city inhabitants presented anti-SARS-CoV-2 antibodies at the end of the first wave, with significant differences between settings. Wearing masks and face shields were associated with lower rate of seropositivity; however, efforts must be made to sustain them over time since there is still a high proportion of susceptible people. PeerJ Inc. 2021-09-20 /pmc/articles/PMC8459728/ /pubmed/34616616 http://dx.doi.org/10.7717/peerj.12149 Text en ©2021 Huamani et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Virology Huamaní, Charles Velásquez, Lucio Montes, Sonia Mayanga-Herrera, Ana Bernabé-Ortiz, Antonio SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study |
title | SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study |
title_full | SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study |
title_fullStr | SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study |
title_full_unstemmed | SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study |
title_short | SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study |
title_sort | sars-cov-2 seroprevalence in a high-altitude setting in peru: adult population-based cross-sectional study |
topic | Virology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459728/ https://www.ncbi.nlm.nih.gov/pubmed/34616616 http://dx.doi.org/10.7717/peerj.12149 |
work_keys_str_mv | AT huamanicharles sarscov2seroprevalenceinahighaltitudesettinginperuadultpopulationbasedcrosssectionalstudy AT velasquezlucio sarscov2seroprevalenceinahighaltitudesettinginperuadultpopulationbasedcrosssectionalstudy AT montessonia sarscov2seroprevalenceinahighaltitudesettinginperuadultpopulationbasedcrosssectionalstudy AT mayangaherreraana sarscov2seroprevalenceinahighaltitudesettinginperuadultpopulationbasedcrosssectionalstudy AT bernabeortizantonio sarscov2seroprevalenceinahighaltitudesettinginperuadultpopulationbasedcrosssectionalstudy |